Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapy of Primary Liver Cancer
Mei Feng, Yisheng Pan, Ruirui Kong, et al.
The Innovation (2020) Vol. 1, Iss. 2, pp. 100032-100032
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

MoS2-based nanocomposites for cancer diagnosis and therapy
Jian-Ling Wang, Sui Li-hua, Jia Huang, et al.
Bioactive Materials (2021) Vol. 6, Iss. 11, pp. 4209-4242
Open Access | Times Cited: 181
Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
Xiaojing Du, Biwei Yang, Quanlin An, et al.
The Innovation (2021) Vol. 2, Iss. 2, pp. 100103-100103
Open Access | Times Cited: 113
Theranostic nanoparticles with disease-specific administration strategies
Peisen Zhang, Yingying Li, Wen Tang, et al.
Nano Today (2021) Vol. 42, pp. 101335-101335
Closed Access | Times Cited: 86
Nanotechnology-enhanced immunotherapy for metastatic cancer
Peisen Zhang, Junli Meng, Yingying Li, et al.
The Innovation (2021) Vol. 2, Iss. 4, pp. 100174-100174
Open Access | Times Cited: 69
Embolization therapy with microspheres for the treatment of liver cancer: State-of-the-art of clinical translation
Alexandre Pérez-López, Cristina Martín‐Sabroso, Laura Gómez-Lázaro, et al.
Acta Biomaterialia (2022) Vol. 149, pp. 1-15
Open Access | Times Cited: 54
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
Bohan Wang, Yachong Liu, Zhibin Liao, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
RETRACTED ARTICLE: Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis
Linpei Wang, Jing Lin, Xiaoqiu Ma, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 47
Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
Xiaoyu Deng, Qinghua Bi, Shihan Chen, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 43
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Elisa Cauli, Michela Anna Polidoro, Simona Marzorati, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 19
Repression of p53 function by SIRT5-mediated desuccinylation at Lysine 120 in response to DNA damage
Xing Liu, Fangjing Rong, Jinhua Tang, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 4, pp. 722-736
Open Access | Times Cited: 40
Identification of Common Genes and Pathways in Eight Fibrosis Diseases
Chang Gu, Xin Shi, Xuening Dang, et al.
Frontiers in Genetics (2021) Vol. 11
Open Access | Times Cited: 37
MVI-Mind: A Novel Deep-Learning Strategy Using Computed Tomography (CT)-Based Radiomics for End-to-End High Efficiency Prediction of Microvascular Invasion in Hepatocellular Carcinoma
Liyang Wang, Wu Meilong, Rui Li, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2956-2956
Open Access | Times Cited: 23
Photothermal Fibrous Chitosan/Polydopamine Sponge for Intraoperative Hemostasis and Prevention of Tumor Recurrence in Hepatocellular Carcinoma Resection
Lanxin Mu, Luhe Qi, Haitao Long, et al.
Advanced Science (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 15
Characterization of the distinct immune microenvironments between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Siao Jiang, Hao Lu, Yingwei Pan, et al.
Cancer Letters (2024) Vol. 588, pp. 216799-216799
Open Access | Times Cited: 5
CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer
Yanfeng Liu, Fan Wang, Guoquan Yan, et al.
Cancer Letters (2024) Vol. 595, pp. 217006-217006
Closed Access | Times Cited: 5
Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer
Yuqi Feng, Letian Fang, Guangwen Cao
Hepatoma Research (2025)
Open Access
An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential
Małgorzata Guz, Witold Jeleniewicz, Marek Cybulski
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1234-1234
Open Access | Times Cited: 20
AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma
Di Pan, Wanwan Yang, Yao Zeng, et al.
Oncogene (2022) Vol. 41, Iss. 31, pp. 3846-3858
Closed Access | Times Cited: 20
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing
Ravi Jagatia, Ewald Doornebal, Una Rastovic, et al.
EBioMedicine (2023) Vol. 97, pp. 104826-104826
Open Access | Times Cited: 11
DNA damage response-related signatures characterize the immune landscape and predict the prognosis of HCC via integrating single-cell and bulk RNA-sequencing
Hanqi Li, Yu Shi, Yue Li, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112475-112475
Open Access | Times Cited: 4
Protein palmitoylation in hepatic diseases: Functional insights and therapeutic strategies
Ying Wang, Haoyuan Ma, Bowen Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights
Xuran Wang, Bin Zhang, Runqiu Jiang
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Single-cell landscape of dynamic changes in CD8+ T cells, CD4+ T cells and exhausted T cells in hepatocellular carcinoma
Rongqiang Liu, Liang Zhang, Jianguo Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Liver cancer: Current and new drug delivery systems
Samson A. Adeyemi, Lindokuhle M. Ngema, Yahya E. Choonara
Elsevier eBooks (2025), pp. 1-13
Closed Access
Page 1 - Next Page

Scroll to top